WuXi AppTec Tightens Governance With Updated Remuneration Committee Mandate

WuXi AppTec Co., Ltd. Class H ( (HK:2359) ) has issued an update.

WuXi AppTec has revised the terms of reference for its Remuneration and Appraisal Committee, a specialized body under the board of directors responsible for setting performance evaluation standards and remuneration policies for directors and senior management. The updated framework aligns with Chinese corporate law, Hong Kong listing rules, and the company’s articles, strengthening oversight of executive pay, incentive schemes, and stock ownership plans, and reinforcing its overall corporate governance structure.

The committee will comprise three directors, with a majority being independent, and its members will be nominated by the board leadership or a defined proportion of directors and then elected by the full board. An independent director will serve as committee chair and convener, a structure intended to enhance independence, accountability, and transparency in decisions on compensation and performance appraisals, which is relevant for investors and other stakeholders monitoring governance standards.

The most recent analyst rating on (HK:2359) stock is a Hold with a HK$124.00 price target. To see the full list of analyst forecasts on WuXi AppTec Co., Ltd. Class H stock, see the HK:2359 Stock Forecast page.

More about WuXi AppTec Co., Ltd. Class H

WuXi AppTec Co., Ltd. operates in the life sciences and pharmaceutical services industry, providing research, development, and manufacturing support to global healthcare and biotech companies. The company is listed in Hong Kong and maintains a formal corporate governance framework overseen by its board of directors and specialized committees.

Average Trading Volume: 4,883,675

Technical Sentiment Signal: Buy

Current Market Cap: HK$303.7B

Learn more about 2359 stock on TipRanks’ Stock Analysis page.